Nevertheless, it is important to highlight that elevated plasma concentrations of BCAAs in individuals with overweight/obesity and patients with T2DM correlate with insulin resistance30–32 and pharmaceutical stimulation of BCAA oxidation via sodium phenylbutyrate treatment significantly increases insulin sensitivity T2DM patients33. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.